Octreotide Acetate
- Product NDC
- 0703-3333
- 11-digit product format
- 007033333
- Labeler code
- 0703
- Product ID
- 0703-3333_2f5b5421-18fe-47d0-8807-b1478eb82b37
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Octreotide Acetate
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Teva Parenteral Medicines, Inc.
- Application
- ANDA075959
- Marketing category
- ANDA
- Marketing start
- 2005-11-23
- Marketing end
- 0000-00-00
- Substance
- OCTREOTIDE ACETATE
- Active strength
- 200 ug/mL
- Pharmacologic classes
- Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0703-3333-01 | 00703333301 | 1 VIAL, MULTI-DOSE in 1 CARTON (0703-3333-01) > 5 mL in 1 VIAL, MULTI-DOSE | 2005-11-23 | 0000-00-00 | No | No | Current |